Stephen Hahn, AP
August 27, 2020 06:52 AM EDTUpdated 10:20 AM
Bioregnum
Coronavirus
Opinion

FDA com­mish Hahn spot­lights Oct 22 vac­cine ad­vi­so­ry meet­ing as the next big flash­point in the Covid-19 cam­paign

John Carroll

Editor & Founder

Mark Oc­to­ber 22 on your cal­en­dars if you want to watch the next big con­tro­ver­sy over the rapid-fire de­vel­op­ment of Covid-19 vac­cines play out at …

Endpoints Premium

This article is available only to Premium subscribers

Upgrade to Premium for unlimited access and Premium exclusives.

UPGRADE
TRENDING NOW

Pfiz­er look­ing to sell hos­pi­tal drugs unit — re­ports

As­traZeneca CEO reaf­firms com­mit­ment to Chi­na fol­low­ing ex­ec­u­tive's de­ten­tion

'Ex­per­tise is a re­al thing': FDA com­mis­sion­er warns of po­lit­i­cal risk to agency

Mer­ck, As­traZeneca tout Phase 3 win for can­cer-turned-rare dis­ease drug

No­var­tis pays $150M up­front to Schrödinger in new drug deal, ramps up soft­ware use

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times